TaiwanForeign medical devices manufacturers must appoint a TFDA-recognized local legal representative before registering any device in Taiwan. Taevas Global provides end-to-end legal representation services that keep your regulatory pathway compliant, your time
Our legal representation service for Taiwan's medical devices market is built on six interconnected pillars that together cover every regulatory, commercial, and compliance dimension your team needs.
Taevas Global acts as your officially designated local legal representative registered with the Taiwan Food and Drug Administration. This appointment is a mandatory prerequisite for any foreign manufacturer seeking device market authorization in Taiwan. We hold the legal standing to submit, receive, and respond to all TFDA correspondence on your behalf.
Our four-step engagement process takes you from initial scoping through TFDA appointment and active registration filing, with clear milestones and accountable timelines at every stage.
We begin by reviewing your device portfolio, existing regulatory certifications, and target Taiwan market timeline. This scoping session identifies the applicable device classes, likely registration pathways, and any documentation gaps that need to be addressed before filing. You receive a written scope summary and a proposed engagement plan within three business days.
During this phase our team collects your existing technical documentation, CE marking or FDA clearance records, ISO 13485 certificates, and intended use descriptions. We map each device against the TFDA classification database and flag items requiring additional clinical or performance data. The output is a prioritized action list that forms the basis of the engagement agreement.
Taiwan hosts a dense cluster of medical device manufacturers concentrated in the northern and central science parks, with particular strength in diagnostics, imaging equipment, and minimally invasive surgical tools. The island's precision manufacturing heritage from the semiconductor and electronics industries has translated directly into world-class medical device production capabilities. This makes Taiwan both a target market and a potential manufacturing partner for foreign entrants.
Taiwan's Medical Devices Act, which came fully into force in 2021, significantly modernized the regulatory framework and aligned it more closely with international standards including IMDRF guidelines. TFDA requires all foreign manufacturers to maintain a locally appointed legal representative who bears direct legal accountability for compliance. The framework includes mandatory post-market surveillance, adverse event reporting, and quality system audits for higher-risk device classes.
Taiwan's single-payer National Health Insurance system covers approximately 99 percent of the population and is a primary procurement channel for medical devices used in hospital and clinical settings. Securing NHI reimbursement listing is often as commercially important as obtaining TFDA registration, and the two processes require coordinated planning. Devices not listed under NHI face a significantly narrower commercial addressable market in the public hospital sector.
Despite its manufacturing strengths, Taiwan imports a significant share of high-value medical devices including cardiac implants, orthopedic systems, robotic surgical platforms, and advanced diagnostic imaging equipment. This import dependency creates substantial commercial opportunity for foreign manufacturers with innovative or premium-tier devices. The United States, Germany, and Japan are the leading source countries for medical device imports into Taiwan.
Our Legal Representation service for Medical Devices in Taiwan is delivered as a structured package covering every document, filing, and advisory touchpoint your team needs from appointment through active compliance.
Fully executed appointment documentation submitted to TFDA, including notarized power of attorney in Traditional Chinese and official appointment confirmation from the regulator.
Written report documenting the risk class determination for each device in your Taiwan portfolio, with regulatory rationale and recommended registration pathway.
Detailed review of your existing technical documentation against TFDA requirements, with a prioritized gap closure plan and timeline for each device.
A 12-month forward-looking compliance calendar covering all TFDA filing deadlines, renewal dates, post-market reporting obligations, and labeling review milestones.
End-to-end management of the import license application tied to your TFDA registration, including coordination with customs authorities and distribution partners.
A structured briefing document and advisory session for your Taiwan distributors covering their obligations under the Medical Devices Act and TFDA regulations.
A tailored post-market surveillance plan aligned to your device class, covering adverse event reporting procedures, field safety corrective action workflows, and periodic safety update reporting.
A named Taevas Global regulatory account manager serving as your single point of contact for all TFDA correspondence, queries, and ongoing compliance matters in Taiwan.
You have CE marking or FDA clearance for your device and now want to access the Taiwan market, but you have no local entity, no TFDA relationships, and no experience with the Medical Devices Act. The mandatory legal representative requirement means you cannot submit a single document to TFDA without a locally appointed representative in place. Taevas Global provides that appointment immediately and handles all TFDA interactions from day one.
Taevas Global provides the TFDA-recognized legal representation, regulatory expertise, and local market knowledge that medical device manufacturers need to register, launch, and grow in Taiwan with confidence.